Highlights
IIA supported (ever)1 patentProfile claimed by owner
About
Cell-based Technology Platforms
Pluri creates cell-based products for commercial use and aims to promote global wellbeing and sustainability. The company's technology platform, a patented and validated 3D cell expansion system, advances novel cell-based solutions for a range of initiatives, from medicine and climate change to food scarcity and animal cruelty. Pluri's method is accurate, scalable, cost effective, and consistent from batch to batch. Pluri currently operates in the field of regenerative medicine and food technology and aims to establish partnerships that leverage the company's 3D cell-based technology in additional industries that require effective, mass cell production.
Identity
| Name | Pluri |
|---|---|
| Slug | pluristem-therapeutics |
| Former names | Pluristem Therapeutics |
| Type / kind | startup |
| Crunchbase ID | pluristem-therapeutics |
| Source _id | agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAgL6sq4oLDA |
Status
| Status | active |
|---|---|
| Status reason | Public on NASDAQ on Apr 2003;Public on TASE on Dec 2010; |
| Last update | 2026-05-17 |
Location
| HQ country code | IL |
|---|---|
| HQ region/district | North District |
| HQ city | Haifa |
| HQ address | Matam, Haifa, Israel |
Web & social
| Website | https://pluri-biotech.com/ |
|---|---|
| https://www.linkedin.com/company/226821 | |
| Twitter / X | https://twitter.com/Pluribiotech |
| YouTube | https://www.youtube.com/channel/UC65WAbsbyKFNqvWWkfWZkKQ |
Classifications
Primary sector Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & Development
Technologies
BiologicalsCells
Target customers
Agriculture & FoodCropsHealthcare & Life SciencesLife SciencesBiotechnologyPharmaceuticals
Business models
B2B
Tags
orthopedicsinflammatory-diseasespulmonarybiological-therapyregenerative-medicinestem-cellscell-therapybioprocesscardiovascularpharmaceuticals3d-technologyspace-techpharma-companiespatients
Funding
| Total raised | $136.9M |
|---|---|
| Current stage | Public |
| Market cap | $27.7M |
Raw source document
Show full JSON (0 KB)
{
"0": "s",
"1": "l",
"2": "i",
"3": "m",
"4": "p",
"5": "a",
"6": "g",
"7": "e",
"8": "s",
"9": "_",
"10": "i",
"11": "m",
"12": "p",
"13": "o",
"14": "r",
"15": "t"
}